SF3B1 |
SF3B1, SAP155: Splicing factor 3B subunit 1 |
KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
118.000 |
Evidence |
|
SHC2 |
IPI00401979 |
GRAP |
GRAP: GRB2-related adapter protein |
118.000 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
117.000 |
Evidence |
|
CDK2 |
CDK2: Cell division protein kinase 2 |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
117.000 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
SFRS1 |
SFRS1, ASF, OK/SW-cl.3, SF2, SF2P33: Splicing factor, arginine/serine-rich 1 |
117.000 |
Evidence |
|
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
117.000 |
Evidence |
|
WASPIP |
IPI00552369 |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
117.000 |
Evidence |
|
CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
117.000 |
Evidence |
|
RB1 |
RB1: Retinoblastoma-associated protein |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
117.000 |
Evidence |
|
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
117.000 |
Evidence |
|
GNB2L1 |
Lung cancer oncogene 7 |
LSM2 |
LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 |
117.000 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
117.000 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
117.000 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
STAT3 |
|
117.000 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
117.000 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
STAT3 |
|
117.000 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
117.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
117.000 |
Evidence |
|
FGFR1 |
FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
117.000 |
Evidence |
|
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
117.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
STAT3 |
|
117.000 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
117.000 |
Evidence |
|
TMPRSS9 |
IPI00337305 |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
117.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
117.000 |
Evidence |
|
AP2S1 |
AP2S1, AP17, CLAPS2: AP-2 complex subunit sigma-1 |
AP2A2 |
AP2A2, ADTAB, CLAPA2, KIAA0899: AP-2 complex subunit alpha-2 |
116.000 |
Evidence |
|